ملف تمديد ايجار ل 5 سنوات اخرى
GENTA INC DE/
FORM 8-K
(Current report filing)
Filed 04/08/10 for the Period Ending 04/05/10
Address 200 CONNELL DRIVE
..
BERKELEY HEIGHTS, NJ 07922
Telephone (908) 286-9800
CIK 0000880643
Symbol GETA
SIC Code 2836 - Biological Products, Except Diagnostic Substances
Industry Biotechnology & Drugs
Sector Healthcare
Fiscal Year 12/31
http://www.edgar-online.com
© Copyright 2010, EDGAR Online, Inc. All Rights Reserved.
Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
Pre -commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
Pre -commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Date of report (Date of earliest event reported): April 5, 2010
GENTA INCORPORATED
(Exact Name of Registrant
as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
0-19635 33-0326866
(Commission File Number) (IRS Employer Identification No.)
200 Connell Drive
Berkeley Heights, NJ
07922
(Address of Principal Executive Offices) (Zip Code)
(908) 286-9800
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Item 1.01. Entry into a Material Definitive Agreement.
On April 5, 2010, Genta Incorporated (the “Company”), entered into an Amendment of its Lease Agreement with The Connell Company,
(“Connell”) a corporation based in New Jersey, whereby the Company extended its lease of office space in Berkeley Heights, New Jersey for
an additional five years until August 31, 2015. In addition, the Amendment extends the payment of approximately $2.0 million owed by the
Company to Connell that had been due on January 1, 2011, to the earlier of 1) August 31, 2015, 2) the date that the company receives an upfront
cash payment totaling at least $15.0 million from a business development deal or 3) the date which is 6 months after the date that the
Company receives approval from the U.S. Food and Drug Administration for either Genasense® or Tesetaxel.
The foregoing summary of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, which
will be filed as an exhibit on the Company’s Form 10-Q.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
GENTA INCORPORATED
Date: April 8, 2010 By: /s/ GARY SIEGEL
Name: Gary Siegel
Title: Vice President Finance